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Summary
The high level of translational fidelity is ensured by various types of quality control
mechanisms, which are adapted to prevent or correct naturally occurring mistakes. Accu-
rate aminoacyl-tRNA synthesis is mostly dependent on the specificity of the aminoacyl-
-tRNA synthetases (aaRS), i.e. their ability to choose among competing structurally similar
substrates.
Our studies have revealed that accurate seryl-tRNA synthesis in yeast and plants is
accomplished via tRNA-assisted optimization of amino acid binding to the active site of
seryl-tRNA synthetase (SerRS). Based on our recent kinetic data, a mechanism is proposed
by which transient protein : RNA complex activates the cognate amino acid more efficiently
and more specifically than the apoenzyme alone. This may proceed via a tRNA-induced
conformational change in the enzyme’s active site. The influence of tRNASer, on the activa-
tion of serine by SerRS variants mutated in the active site, is much less pronounced. Altho-
ugh SerRS misactivates structurally similar threonine in vitro, the formation of such erro-
neous threonyl-adenylate is reduced in the presence of nonchargeable tRNASer analog.
Thus, the sequence-specific tRNA : SerRS interactions enhance the accuracy of amino acid
recognition.
Another type of quality control mechanism in tRNA serylation is assumed to be based
on the complex formation between SerRS and a nonsynthetase protein. Using in vivo inter-
action screen, yeast peroxin Pex21p was identified as SerRS interacting protein. This was
confirmed by an in vitro binding assay. Kinetic experiments performed in the presence of
Pex21p revealed that this peroxin acts as an activator of seryl-tRNA synthetase in the
aminoacylation reaction.
Key words: aminoacyl-tRNA synthetase, tRNA-dependent amino acid recognition, amino
acid selection, protein-protein interactions, activation of aminoacylation
Introduction
A cell places a high priority on ensuring that trans-
lation produces proteins that accurately reflect the corre-
sponding genetic information (1). Still, translation is less
accurate than other processes in transmition of genetic
information. This inaccuracy is due mostly to erroneous
selection of aminoacyl-tRNAs by the ribosomes, but the
aminoacyl-tRNA synthetases (aaRS) are also responsible
for the occurrence of translational mistakes. These en-
zymes catalyze the esterification of tRNAs with their
cognate amino acids with relatively high specificity (2).
The error in the selection of correct amino acids is in the
range of 10–4–10–5 in vitro. The selectivity toward tRNA
is even greater: the frequency of errors involving non-
cognate tRNA aminoacylation is in most cases 10–6 or
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lower (3). The accuracy of these processes is enhanced in
vivo, since the quality control mechanisms exist, which
can further prevent or correct the errors.
Basic rules that govern the recognition and specific-
ity in aminoacylation reaction are illustrated in Fig. 1.
Precision in the choice of amino acid by the cognate
aaRS depends on natural chemical diversity of these
compounds in the cell. The differences in amino acid
side chains are often sufficient to allow their specific
binding. The essential principle in achieving high speci-
ficity is the rejection of smaller substrates with similar
side chain chemistry or isosteric amino acids. Amino-
acyl-tRNA synthetases specific for amino acids, which
have structurally similar analogs, often possess editing
activity. They can correct erroneously activated amino
acids and misacylated tRNAs (4–7). However, during
the editing process, some of the correct products are also
destroyed (8). This makes corrective pathways energeti-
cally very costly, and they are disfavored in the cell. Al-
ternatively, the quality of aminoacyl-tRNA synthesis in
the cell can be improved by the mechanisms that en-
hance the accuracy of substrate discrimination and con-
sequently prevent errors. The examples are metallo-
enzymes, threonyl- and cysteinyl-tRNA synthetases. In
both cases, improved amino acid selection is based on
the fact that only the binding of cognate (or chemically
very similar amino acid) to the active site changes the
coordination geometry of zinc and prevents the interfer-
ence of other substrates (9–11). In seryl-tRNA synthesis,
prevention of errors can be achieved by cognate tRNA:
synthetase complex formation (12). On the other hand,
the selection of the correct tRNA is assumed to occur as
a result of preferential reaction kinetics for cognate pro-
tein-RNA complexes. This means that the accuracy of
this process is enhanced by the stabilization of the tran-
sition state for charging and the existence of the anti-
determinants in certain tRNAs that prevent interaction
with noncognate aaRSs. The specificity and efficiency of
aminoacylation can be further increased by the interac-
tion of aaRS with nonsynthetase proteins (13,14).
Results and Discussion
The accuracy of seryl-tRNA formation
In general, the accuracy of seryl-tRNA synthesis is
determined mostly by the interaction of a serine -OH
group with the enzymes' active site (15) and the specific
recognition between the long N-terminal coiled coil
(contained in all SerRSs except those from animal mito-
chondria) and the long variable arm of tRNASer (16,17).
Other structural elements of cognate tRNAs, as the se-
quence of the acceptor stem and the overall macromole-
cular shape, further define the serylation specificity in
various organisms (18–20). Due to our interest in evolu-
tion of tRNA determinants, the differences in the recog-
nition of substrates, and most recently in quality control
mechanisms, we have been studying SerRS enzymes
from several sources in our laboratory for many years.
Special emphasis was given to the comparison of seryl-
-tRNA formation in different cellular compartments.
All seryl-tRNA synthetases, except those function-
ing in animal mitochondria and methanogenic archaea,
have rather conserved primary structures. Without ex-
ception, SerRSs are homodimers, with two active sites
for seryl-adenylate formation (21,22). The most con-
served regions involve so called signature motifs: motif
1, which is important for dimerization, and motifs 2 and
3, which make up the active site and are involved in
binding of all three substrates: ATP, serine and the
3'-end of tRNA. Schematic representation of conserved
domains in eukaryotic seryl-tRNA synthetases is given
in Fig. 2. Organellar enzymes have N-terminal import
sequences, while all eukaryotic cytosolic enzymes have
very basic C-terminal extensions (22). These C-terminal
peptides are dispensable for cell viability but are in-
volved in substrate recognition and overall stabilization
of SerRS structure (23). According to structure model-
ing, the C-terminal extension of yeast SerRS flips back
and interacts with the active site (Fig. 2). This interac-
tion may be either direct or possibly bridged by another
SerRS-interacting protein. Although we have accumula-
ted some experimental evidence in support of this mo-
del (see below), final conclusion must await further
structural studies, since none of the eukaryotic seryl-
-tRNA synthetases have yet been crystallized. In order
to test structural and functional similarity between se-
ryl-tRNA synthetases from various organisms, we have
performed mutational analysis of yeast SerRS and ana-
lyzed the mutants in vivo and in vitro. Our experiments
revealed that yeast SerRS structurally resembles its bac-
terial counterparts in the active site (24).
248 I. WEYGAND-DURASEVIC et al.: Seryl-tRNA Synthesis, Food Technol. Biotechnol. 40 (4) 247–253 (2002)
CHOOSING THE CORRECT AMINO ACID
achieved through the differences in binding energies
Mechanisms that enhance
the accuracy of amino
acid selection:
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Fig. 1. Recognition and specificity in aminoacylation reaction.
Selection of proper amino acid and tRNA by aminoacyl-tRNA
synthetases are crucial steps in maintaining the fidelity of trans-
lation
Substrate recognition by yeast SerRS
Yeast dimeric SerRS binds two tRNASer molecules
with very different affinities (12). Interestingly, the bind-
ing is anticooperative and currently we are not able to
predict the biological significance of this unusual mode
of macromolecular interaction. However, cognate tRNA
is not only the substrate, but it also mediates in serine
recognition. In the presence of tRNA, Km value for se-
rine is decreased for an order of magnitude, indicating
that sequence specific tRNA:SerRS interactions optimize
the binding of serine. This is the consequence of tRNA-
-induced conformational change in the enzyme's active
site. Two structural features of SerRS are crucial for tRNA-
-dependent serine recognition: the flexibility of motif 2
loop and the presence of C-terminal peptide (Fig. 3). Ac-
cording to structure modeling, alteration of glycines in
the conserved motif 2 loop may cause the formation of
more rigid conformation (17). Kinetic analysis of muta-
ted yeast SerRS variants (SerRSmut4, Gly291Val; SerRS-
mut5, Glu281Asp, Gly291Ala) revealed that the replace-
ment of conserved glycines disables mutated enzymes
to recognize serine in tRNA-assisted manner. Conse-
quently, these mutants complemented Saccharomyces cere-
visiae null allele strain only weakly.
In order to get better insight into the mechanism of
tRNA-dependent serine recognition, we have generated
nonchargeable, 3'-truncated tRNA analog (tRNASerCC)
and used it as potential conformational modulator in
seryl-adenylate synthesis. According to our kinetic stud-
ies, the addition of equimolar amount of cognate, ho-
mologous tRNASer per dimeric yeast SerRS was capable
of inducing the complete rearrangement of the amino
acid binding site, as judged by almost equal affinities
for serine in tRNA-assisted seryl-adenylate formation
and aminoacylation reaction. Molar surplus of tRNA
did not significantly affect serine binding properties.
This may suggest that the conformational change occurs
concomitantly at both subunits, since two seryl-adenyla-
tes were formed per mol of SerRS (22). Heterologous
(bacterial) tRNASer, which shares only some identity ele-
ments with yeast tRNASer isoacceptors, is a less potent
conformational modulator, as shown by kinetic analysis
(Fig. 4). It is in good agreement with our previous re-
sults (25) that bacterial tRNASer is a very poor substrate
for yeast SerRS, both in vivo and in vitro.
As judged by the comparison of the specificity con-
stants, SerRS:tRNA complex activates cognate amino
acid more efficiently and more specifically than the apo-
enzyme alone (Fig. 5).
Misactivation of threonine
Seryl- and threonyl-tRNA synthetases are evolution-
ary and structurally related enzymes which recognize
amino acids with beta-hydroxyl group. The hydroxyl
groups of both amino acids make important contribu-
tion to specificity of recognition by their respective ami-
noacyl-tRNA synthetases (9,15). Thus, slight misactivation
of threonine by yeast SerRS is not surprising. However,
the formation of erroneous threonyl-adenylate is re-
duced in the presence of inactivated tRNASer, indicating
that the sequence-specific tRNA:SerRS interactions en-
hance the accuracy of amino acid recognition. Misacti-
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Fig. 2. Seryl-tRNA synthetase (SerRS) from yeast. (A): Sche-
matic representation of domain arrangement in SerRS protein.
Class conserved motif 1 is a part of the dimer interface, while mo-
tifs 2 and 3 interact with the substrates (ATP, amino acid and 3’
end of tRNA). Motif 2 loop, which is a part of active site, is shown
in black. C-terminal extension characteristic of eukaryotic
cytosolic enzymes is shown in dark gray. Numbers define amino
acids comprised in indicated regions. (B): Model of yeast SerRS
subunit. The model is based upon coordinates of SerRS from T.
thermophilus (1ses.pdb). The position of the motif 2 loop (black)
and the C-terminal extension (dark gray) of yeast enzyme are
shown in the structural context.
Fig. 3. Comparison of Km values for serine in aminoacylation re-
action (black bars) and amino acid activation (gray bars).
Higher affinity for serine in the reaction performed in the pres-
ence of tRNA reveals conformational readjustment of amino acid
binding site in SerRS : tRNA complex. Mutations in the motif 2
loop (SerRSmut4, Gly291Val; SerRSmut5, Glu281Asp, Gly291-
Ala) as well as the truncation of C-terminal extension (SerRSC20)
impair tRNA-dependent serine recognition.
vation of threonine by mutant SerRS (SerRSmut5, Glu-
281Asp, Gly291Ala) is more pronounced than with wild
type enzyme, showing that mutated aaRS has more re-
laxed specificity. It seems that mutants are partly de-
prived of quality control mechanisms, as a consequence
of less flexible motif 2 loop. Although the determination
of Km value for threonine was not very precise because
of its low misactivation (which is about 0.4 %), it is evi-
dent that the ratio of Km values for threonine and serine is
very different when measured without and with tRNASer.
In the absence of tRNA it is estimated to be only about
eight (Km for threonine is about 4 mM vs. Km for serine
which is 0.5 mM). This ratio is raised for an order of
magnitude in the presence of tRNASerCC, due to a pro-
found effect of tRNA on serine affinity and almost neg-
ligible influence on threonine binding (Fig. 6).
tRNA-dependent discrimination of amino acids as a
quality control mechanism in serylation
Consistent with the crystallographic data on Thermus
thermophilus SerRS (17) and our biochemical studies (12),
serylation in vivo is achieved by a tRNASer : SerRS com-
plex as a macromolecular catalyst that discriminates ami-
no acids with high specificity. The initial interaction be-
tween the long extra arm of tRNASer and N-terminal
SerRS coiled-coil positions the 3’-end of cognate tRNA
into the active site of another subunit. Either tRNA : SerRS
docking interactions or the interaction of the tRNA ac-
ceptor end with motif 2 loop residues induce the con-
formational change in the active site and increase the af-
finity for serine. Conformational flexibility of exposed
motif 2 loop seems to be important for this structural re-
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Fig. 4. Binding of nonchargeable tRNAsSer increases the SerRS
affinity for serine in the activation reaction. Km values for serine
were determined in the amino acid activation reaction in the ab-
sence (tRNA/SerRS was 0) and presence (tRNA/SerRS was 1
and 5) of nonchargeable tRNAsSer. (A): tRNA/SerRS
 2 represents
molar ratio of tRNA and SerRS dimer. (B): tRNA/SerRSmut5
 2
represents molar ratio of tRNA and SerRSmut5 (Glu281Asp,
Gly291Ala) dimer.
Fig. 5. SerRS:tRNASer complex is kinetically optimized species
for serine activation. Specificity constants (kcat/Km) were evalu-
ated from Km and kcat values determined in the amino acid activa-
tion reaction in the absence (– tRNA) and presence (tRNASerCC
and tRNASerE. coli) of nonchargeable tRNAs
Ser
CC.
Fig 6. Nonchargeable tRNASer decreases the misactivation of
theronine by yeast SerRS. Km (Thr)/ Km (Ser) ratios were calcu-
lated from Km values for theronine and serine determined in the
amino acid activation reaction in the absence (– tRNA) and pres-
ence (+ tRNA) of nonchargeable tRNASerCC.
adjustment. We suggest that SerRS misacylation errors
are diminished by the described mechanism, making the
editing function unnecessary. So far, tRNA-dependent
amino acid discrimination has been proven for yeast cy-
tosolic enzyme and maize mitochondrial SerRS (12,24,26),
but we assume that the same mode of serine recognition
could be universally employed by all seryl-tRNA syn-
thetases.
Does yeast SerRS need protein cofactor(s) to improve
the specificity of tRNA recognition?
Aminoacyl-tRNA synthetases in general do not re-
quire protein cofactors for activity and specificity of
substrate recognition. Instead, idiosyncratic domains are
attached or inserted in the conserved class defining cata-
lytic core (27–29), and are responsible for binding and
recognition of cognate tRNAs (2,21). However, in higher
eukaryotes, these enzymes are known to participate in
complex formation with other synthetases and nonsyn-
thetase proteins (30–36). Although in yeast such large
complexes have not been found, smaller complex con-
taining two class I synthetases, MetRS and GluRS, and
protein Arc1p were identified (13,37,38), confirming the
existence of an evolutionary intermediate toward higher-
-order organization of aaRSs. Arc1p is the first example
of a protein that is not itself an enzyme but is required
for the efficient aminoacylation in eukaryotic cells. Arc1p
interacts with a subset of tRNAs, but its binding of
tRNASer isoacceptors was shown to be negligible (13).
Several lines of evidence from our laboratory sug-
gest that yeast SerRS may interact with another cellular
protein. The enzyme comprises positively charged C-ter-
minal extension, whose truncation leads to toxicity in
vivo, due to altered substrate recognition (23). However,
truncated SerRS has even somewhat higher affinity for
native tRNA in vitro, indicating that C-terminal peptide
is not a tRNA binding domain. tRNA-dependent serine
recognition is impaired after truncation of C-terminal
peptide, suggesting that it either stabilizes the proper
conformation of the active site, or directly leads the
3'-end of tRNA into the active site. We reasoned that the
stabilization of the SerRS active site could also be medi-
ated via the interaction between the C-terminal peptide
and another cellular protein.
In order to find out whether SerRS interacts specifi-
cally with other cellular components of S. cerevisiae, we
screened yeast cDNA library using the two-hybrid sys-
tem with SerRS as a bait. Five positives were selected
and sequenced. We identified yeast peroxin Pex21p as
SerRS interacting protein. The interaction was confirmed
in vitro using GST pull-down. Pex21p is a protein of 288
amino acid residues with calculated molecular weight of
33045 Da. It is a member of yeast peroxin family and is
engaged in peroxisomal biogenesis (39). Together with
Pex18p (which shares 23 % of overall identity), Pex21p
is required for peroxisomal localization of Pex7, and
therefore is important for protein targeting via the
peroxisomal targeting signal 2 pathway (PTS2). To re-
veal functional significance of Pex21p-SerRS interaction,
we purified Pex21p and showed that Pex21p increases
the efficiency of aminoacylation by SerRS in vitro (Fig. 7;
Table 1). This unusual interaction reflects another func-
tion of the peroxin, related to the activity of serylation,
since Pex21p acts as an activator of SerRS. The interac-
tion between SerRS and Pex21p does not affect the affin-
ity for tRNA, showing that different mechanisms are
employed by Pex21p and Arc1p in enhancing the ami-
noacylation efficiency and specificity.
Outlook
We have shown that the accuracy of seryl-tRNA
synthesis is enhanced by two quality control mecha-
nisms: (i) tRNA-dependent amino acid recognition, (ii)
SerRS-Pex21p interaction. The first mechanism decreases
the misacylation of tRNASer isoacceptors with structur-
ally similar, noncognate amino acids, and the second en-
hances the overall aminoacylation efficiency. In both
cases, the macromolecular complex acts as more effi-
cient and more specific catalyst than the apoenzyme
alone. The optimization of serine binding and conse-
quently better discrimination against noncognate amino
acids is achieved by the conformational change in the
enzyme's active site, which requires flexible motif 2
loop. The mechanism used by Pex21p in affecting the
serylation activity of SerRS is still unknown. The experi-
ments related to mapping the SerRS/Pex21p interactive
domains are in progress. Since the analysis of Pex21p
amino acid sequence predicts a potential nuclear local-
ization signal, also found in Arc1p, it is possible that
Pex21p functions in nucleus as well, maybe as a part of
an aminoacylation dependent nuclear tRNA export
pathway in yeast (40–42). In this respect, it would be in-
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Fig. 7. Pex21p activates yeast seryl-tRNA synthetase. Kinetic
analysis of SerRS aminoacylation reaction at different concentra-
tions of Pex21p. Amounts of seryl-tRNASer formed in aminoacy-
lation were plotted against the molar ratio of Pex21p and SerRS.







–Pex21p 0.0088 62.5 0.19
+Pex21p 0.0260 20.0 0.15
teresting to find out whether this protein is involved in
regulating SerRS subcellular distribution, as recently de-
termined for Arc1p complexed with GluRS and MetRS
(43).
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To~nost sinteze seril-tRNA
Sa`etak
To~nost biosinteze proteina nadziru razli~iti kontrolni mehanizmi koji spre~avaju ili
ispravljaju gre{ke u translaciji. Specifi~nost aminoacil-tRNA-sintetaza (aaRS) pri izboru i
kovalentnom povezivanju pripadnih aminokiselina i tRNA klju~na je u ovom procesu.
Istra`ivanja u na{em laboratoriju pokazala su da se specifi~nost i u~inkovitost sinteze
seril-tRNA u kvascu i biljkama pove}avaju tRNA-ovisnim prilago|avanjem veznog mjesta
za serin u aktivnom mjestu seril-tRNA-sintetaze (SerRS). Dakle, makromolekularni kom-
pleksi tRNA i enzima imaju bolja kataliti~ka svojstva od apoenzima. Na{i rezultati kinetike
pokazuju da se vezanjem tRNA bitno mijenja konformacija veznog mjesta za serin u enzi-
mu divljeg tipa, dok je konformacijska promjena slabija kod enzima s mutacijama u aktiv-
nom mjestu. Iako SerRS mo`e aktivirati i serinu sli~an treonin, stvaranje treonil-adenilata
smanjeno je u prisutnosti aminoacilacijski inaktivnog analoga tRNA. Time je pokazano da
su interakcije izme|u pripadne tRNA i SerRS bitne za to~an izbor aminokiseline.
Djelotvornost serilacije pove}ava se i interakcijom SerRS s nesintetaznim proteinom,
peroksinom Pex21p. Ta neo~ekivana interakcija uo~ena je prvo in vivo, pretragom kva{~e-
ve biblioteke u sustavu dvaju hibrida sa SerRS kao interakcijskim proteinom. Interakcija je
potvr|ena in vitro. Kineti~ki eksperimenti pokazali su da Pex21p djeluje kao aktivator
SerRS, {to ovu neobi~nu interakciju ~ini biolo{ki zna~ajnom jer pove}ava u~inkovitost
aminoaciliranja.
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